Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31.3M
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
-313K
-
Total reported value, excl. options
-
$1.24B
-
Value change
-
-$12.2M
-
Put/Call ratio
-
0.53
-
Number of buys
-
59
-
Number of sells
-
-69
-
Price
-
$44.17
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2016
164 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2016.
CONMED Corp - Common Stock (CNMD) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 31.3M outstanding shares and own 89.44% of the company stock.
Largest 10 shareholders include SCOPIA CAPITAL MANAGEMENT LP (2.77M shares), DIMENSIONAL FUND ADVISORS LP (2.35M shares), VANGUARD GROUP INC (2.18M shares), BlackRock Fund Advisors (2.1M shares), VICTORY CAPITAL MANAGEMENT INC (1.91M shares), Champlain Investment Partners, LLC (1.48M shares), Capital Research Global Investors (1.25M shares), Capital World Investors (1.11M shares), GOLDMAN SACHS GROUP INC (1.04M shares), and CRAMER ROSENTHAL MCGLYNN LLC (1.02M shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.